Survival according to stage for 160 thymic carcinoids reported to the SEER database

SEER stage	Survival rates
SEER stage	One year	Three year	Five year
Localized	97 percent	91 percent	80 percent
Regional	88 percent	64 percent	48 percent
Distant	81 percent	48 percent	31 percent
Overall	89 percent	66 percent	53 percent

SEER: Surveillance, Epidemiology and End Results database of the United States National Cancer Institute.

Reproduced with permission from: Gaur P, Leary C, Yao JC. Thymic Neuroendocrine Tumors. A SEER database analysis of 160 patients. Ann Surg 2010; 251:1117. Copyright © 2010 Lippincott Williams & Wilkins.

Graphic 53758 Version 6.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟